The Part D coverage gap reform in 2011 improved adherence to diabetes medications in the coverage gap.
Bimal V. Patel, PharmD, MS
Advertisement
Articles by Bimal V. Patel, PharmD, MS
The coverage gap in the Medicare Part D program has a significant negative impact on adherence to diabetes medications.
About half of the patients in this study did not fill any smoking cessation medication following a rejected claim for varenicline.
Advertisement
Latest Updated Articles
- Utilization Management for Smoking Cessation Pharmacotherapy: Varenicline Rejected Claims Analysis
Published: September 22nd 2010 | Updated:
- Part D Coverage Gap and Adherence to Diabetes Medications
Published: December 21st 2010 | Updated:
- Effects of Coverage Gap Reform on Adherence to Diabetes Medications
Published: April 22nd 2013 | Updated:
Advertisement
Advertisement
Trending on AJMC
1
Dual JAK Inhibition Demonstrates Efficacy in Progressive Nonsegmental Vitiligo
2
FDA Approves Guselkumab for Pediatric Plaque Psoriasis, Active Psoriatic Arthritis
3
Nerandomilast a "No-Brainer" for First-Line Pulmonary Fibrosis Therapy: Justin M. Oldham, MD, PhD, MS
4
Evaluating Current Breast Cancer Care, Treatments: Lakshminarayanan Nandagopal, MD
5
